The Spectrum of Tigecycline-Induced Pancreatitis in Clinical Characteristics, Diagnosis, and Management

References

• Yaghoubi S, Zekiy AO, Krutova M, et al. Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review. Eur J Clin Microbiol Infect Dis. 2022;41(7):1003–1022. doi:10.1007/s10096-020-04121-1
   PubMed Web of Science ®Google Scholar
• Paul M, Carrara E, Retamar P, et al. European Society of clinical microbiology and infectious diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant gram-negative bacilli (endorsed by ESICM -European Society of intensive care Medicine). Clin Microbiol Infect. 2022;28(4):521–547. doi:10.1016/j.cmi.2021.11.025
   PubMed Web of Science ®Google Scholar
• Kechagias KS, Chorepsima S, Triarides NA, et al. Tigecycline for the treatment of patients with Clostridium difficile infection: an update of the clinical evidence. Eur J Clin Microbiol Infect Dis. 2020;39(6):1053–1058. doi:10.1007/s10096-019-03756-z
   PubMed Web of Science ®Google Scholar
• Gilson M, Moachon L, Jeanne L, et al. Acute pancreatitis related to tigecycline: case report and review of the literature. Scand J Infect Dis. 2008;40(8):681–683. doi:10.1080/00365540801938949
   PubMed Web of Science ®Google Scholar
• Wyeth Pharmaceutics. Tygacil [package insert]. Philadelphia: Wyeth Pharmaceutics. Tigecycline is a structural derivative of minocycline and shares similar pharmacokinetic properties and most of the adverse effects with tetracyclines; 2009.
   Google Scholar
• McGovern PC, Wible M, Korth-Bradley JM, et al. Pancreatitis in tigecycline Phase 3 and 4 clinical studies. J Antimicrob Chemother. 2014;69(3):773–778. doi:10.1093/jac/dkt427
   PubMed Web of Science ®Google Scholar
• Okon E, Engell C, van Manen R, et al. Tigecycline-related pancreatitis: a review of spontaneous adverse event reports. Pharmacotherapy. 2013;33(1):63–68. doi:10.1002/phar.1159
   PubMed Web of Science ®Google Scholar
• Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis 2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102–1l. doi:10.1136/gutjnl-2012-302779
   PubMed Web of Science ®Google Scholar
• Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–245. doi:10.1038/clpt.1981.154
   PubMed Web of Science ®Google Scholar
• Akhter S, Krishnan P, Kaul P. Tigecycline-associated acute pancreatitis. Am J Ther. 2018;25(6):e749–e750. doi:10.1097/MJT.0000000000000763
   PubMed Web of Science ®Google Scholar
• Chang CY, Qiao W, Wang H, et al. Tigecycline-associated acute pancreatitis in a child with pulmonary cystic fibrosis: a case report and literature review. Int J Clin Pharmacol Ther. 2022;60(1):41–45. doi:10.5414/CP204073
   PubMed Web of Science ®Google Scholar
• Mesa C, Dajoyag-Mejia MA, Issac R, et al. Tigecycline-induced acute pancreatitis with rechallenge: a case report. J Pharm Technol. 2013;29(1):3–8. doi:10.1177/875512251302900102
   Google Scholar
• Hemphill MT, Jones KR. Tigecycline-induced acute pancreatitis in a cystic fibrosis patient: a case report and literature review. J Cyst Fibros. 2016;15(1):e9–e11. doi:10.1016/j.jcf.2015.07.008
   PubMedGoogle Scholar
• Hung WY, Kogelman L, Volpe G, et al. Tigecycline-induced acute pancreatitis: case report and literature review. Int J Antimicrob Agents. 2009;34(5):486–489. doi:10.1016/j.ijantimicag.2009.05.004
   PubMed Web of Science ®Google Scholar
• Lin JW, Wang RD, Chen JH. Tigecycline-induced acute pancreatitis in a renal transplant patient: a case report and literature review. BMC Infect Dis. 2018;18(1):201. doi:10.1186/s12879-018-3103-z
   PubMedGoogle Scholar
• Lipshitz J, Kruh J, Cheung P, et al. Tigecycline-induced pancreatitis. J Clin Gastroenterol. 2009;43(1):93. doi:10.1097/MCG.0b013e318164939c
   PubMed Web of Science ®Google Scholar
• Marot J-C, Jonckheere S, Munyentwali H, et al. Tigecycline-induced acute pancreatitis: about two cases and review of the literature. Acta Clin Belg. 2012;67(3):229–232. doi:10.2143/ACB.67.3.2062663
   PubMed Web of Science ®Google Scholar
• Marshall SR. Tigecycline-induced pancreatitis. Hosp Pharm. 2009;44(3):239–241. doi:10.1310/hpj4403-239
   Google Scholar
• Mascarello M, Papa G, Arnez ZM, et al. Acute necrotizing pancreatitis related to tigecycline. J Antimicrob Chemother. 2012;67(5):1296–1297. doi:10.1093/jac/dkr597
   PubMed Web of Science ®Google Scholar
• Suarez Otero R, Espinoza López D, Ponce Ponce A, et al. Pancreatitis probably induced by tigecycline: a report of a case. Medicina Interna de Mex. 2010;26(3):273–275.
   Google Scholar
• Prot-Labarthe S, Youdaren R, Benkerrou M, et al. Pediatric acute pancreatitis related to tigecycline. Pediatr Infect Dis J. 2010;29(9):890–891. doi:10.1097/INF.0b013e3181e83a85
   PubMed Web of Science ®Google Scholar
• Wang P-F, Zou H, Zhu J-H, et al. Acute pancreatitis caused by tigecycline: a case report and literature review. Medicine. 2021;100(51):e28245. doi:10.1097/MD.0000000000028245
   PubMed Web of Science ®Google Scholar
• Yazirli B, Kara E, Inkaya AC, et al. A case report of tigecycline induced acute pancreatitis in a renal transplant patient and review of the literature: should we avoid tigecycline in patients on calcineurin inhibitors? Transpl Infect Dis. 2021;23(4):e13593. doi:10.1111/tid.13593
   PubMedGoogle Scholar
• Cheng XF, Feng LJ, Wen Y. Analysis of factors inducing acute pancreatitis after kidney transplantation. Pharm Care Res. 2018;18(5):391–393. doi:10.5428/pcar20180520
   Google Scholar
• Gao CH, Wang TY. A case of tigecycline-induced amylase elevation. Chin J Resp Crit Care Med. 2017;16(2):175–177. doi:10.7507/1671-6205.201610002
   Google Scholar
• Li YH, Lu SQ. Tigecycline-induced severe acute pancreatitis and review of the literature. Lingnan J Emerg Med. 2020;25(6):664–666. doi:10.3969/j.issn.1671-301X.2020.06.043
   Google Scholar
• Li Y. A case of acute pancreatitis induced by tigecycline. Her Med. 2018;37(2):263–264. doi:10.3870/j.issn.1004-0781.2018.02.031
   Google Scholar
• Li WJ, Ding YF. Two cases of acute pancreatitis induced by tigecycline after kidney transplantation. Her Med. 2019;38(10):1367–1369. doi:10.3870/j.issn.1004-0781.2019.10.029
   Google Scholar
• Xu G, Xu P, Zhou YG, et al. Tigecycline-induced acute pancreatitis in renal transplant patients: a report of 3 cases. Central South Pharm. 2021;19(6):1265–1268. doi:10.7539/j.issn.1672-2981.2021.06.044
   Google Scholar
• Wu ZY, Zhou XM, Gu X, et al. Acute pancreatitis induced by tigecycline. ADRJ. 2017;19(2):132–133. doi:10.3760/cma.j.issn.1008-5734.2017.02.012
   Google Scholar
• Zhang F, Liao GY. Acute hemorrhagic necrotizing pancreatitis after renal transplantation: a case report and literature review. Fudan Univ J Med Sci. 2021;48(3):423–426. doi:10.3969/j.issn.1672-8467.2021.03.023
   Google Scholar
• Du CH, Zhao YL, Zhao GQ. One case of rare acute pancreatitis induced by tigecycline. Eval Anal Drug-Use Hosp China. 2017;17(10):1311–1312. doi:10.14009/j.issn.1672-2124.2017.10.005
   Google Scholar
• Guo YY, Li LY, Song X, et al. Pancreatitis caused by tigecycline: a rare case report. Clin Case Rep Rev. 2019;5(4):1–3. doi:10.15761/CCRR.1000467
   Google Scholar
• Liu DH, Xing XM, Yang X, et al. Acute pancreatitis induced by tigecycline in a patient after renal transplantation. ADRJ. 2022;24(3):155–157. doi:10.3760/cma.j.cn114015-20210513-00551
   Google Scholar
• Wang ZQ, Ma K, Chen ZJ, et al. Successful treatment of early post-transplant bloodstream and pulmonary infection caused by carbapenem-resistant Klebsiella pneumoniae with a combination of ceftazidime-avibactam and carbapenem: a case report. Transplant Proc. 2020;52(9):2742–2746. doi:10.1016/j.transproceed.2020.08.006
   PubMed Web of Science ®Google Scholar
• Gheith O, Nagib AM, Aboatya H, et al. Tigecycline-induced acute pancreatitis in renal transplant recipient: case report and review of literature. Transplant Int. 2021;34(2):370. doi:10.1111/tid.13593
   Google Scholar
• Davido B, Shourick J, Makhloufi S, et al. True incidence of tigecycline-induced pancreatitis: how many cases are we missing. J Antimicrob Chemother. 2016;71(10):2994–2995. doi:10.1093/jac/dkw255
   PubMed Web of Science ®Google Scholar
• Yang AL, Vadhavkar S, Singh G, et al. Epidemiology of alcohol-related liver and pancreatic disease in the United States. Arch Intern Med. 2008;168(6):649–656. doi:10.1001/archinte.168.6.649
   PubMedGoogle Scholar
• Hung WY, Abreu Lanfranco O. Contemporary review of drug-induced pancreatitis: a different perspective. World J Gastrointest Pathophysiol. 2014;5(4):405–415. doi:10.4291/wjgp.v5.i4.405
   PubMedGoogle Scholar
• Vinklerová I, Procházka M, Procházka V, et al. Incidence severity, and etiology of drug-induced acute pancreatitis. Dig Dis Sci. 2010;55(10):2977–2981. doi:10.1007/s10620-010-1277-3
   PubMed Web of Science ®Google Scholar
• Badalov N, Baradarian R, Iswara K, et al. Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol. 2007;5(6):648–61;quiz 644. doi:10.1016/j.cgh.2006.11.023
   PubMed Web of Science ®Google Scholar
• Slakey DP, Johnson CP, Cziperle DJ, et al. Management of severe pancreatitis in renal transplant recipients. Ann Surg. 1997;225(2):217–222. doi:10.1097/00000658-199702000-00010
   PubMed Web of Science ®Google Scholar
• Danalıoğlu A, Mitchell OJ, Singh VK, et al. Acute pancreatitis following adult liver transplantation: a systematic review. Turk J Gastroenterol. 2015;26(6):450–455. doi:10.5152/tjg.2015.0427
   PubMed Web of Science ®Google Scholar
• Kroner PT, Mareth K, Raimondo M, et al. Acute pancreatitis in advanced chronic kidney disease and kidney transplant recipients: results of a US Nationwide analysis. Mayo Clin Proc Innov Qual Outcomes. 2019;3(2):160–168. doi:10.1016/j.mayocpiqo.2019.03.006
   PubMedGoogle Scholar
• Ogunseinde BA, Wimmers E, Washington B, et al. A case of tacrolimus (FK506)-induced pancreatitis and fatality 2 years postcadaveric renal transplant. Transplantation. 2003;76(2):448. doi:10.1097/01.TP.0000070434.73865.7A
   PubMed Web of Science ®Google Scholar
• Yahiaoui N, Roche M, Aissaoui-Hoffmann N, et al. Intravenous methylprednisolone induced acute pancreatitis. Eur J Clin Pharmacol. 2017;73(5):645–646. doi:10.1007/s00228-017-2207-5
   PubMed Web of Science ®Google Scholar
• Einollahi B, Dolatimehr F. Acute pancreatitis induced by mycophenolate mofetil in a kidney transplant patient. J Nephropharmacol. 2015;4(2):72–74.
   PubMedGoogle Scholar
• Pavan M, Chaudhari AP, Ranganth R. Altered bioavailability of tacrolimus following intravenous administration of tigecycline. Am J Kidney Dis. 2011;57(2):354. doi:10.1053/j.ajkd.2010.10.040
   PubMed Web of Science ®Google Scholar
• Chow KM, Pang WF, Chan GCK, et al. Beware of drug interaction between tigecycline and tacrolimus. Nephrology. 2020;25(1):99–100. doi:10.1111/nep.13594
   PubMed Web of Science ®Google Scholar
• Gagnon A-L, Lavoie A, Frigon M-P, et al. A drug-induced acute pancreatitis retrospective study. Can J Gastroenterol Hepatol. 2020;2020:1516493. doi:10.1155/2020/1516493
   PubMed Web of Science ®Google Scholar
• Balani AR, Grendell JH. Drug-induced pancreatitis: incidence, management and prevention. Drug Saf. 2008;31(10):823–837. doi:10.2165/00002018-200831100-00002
   PubMed Web of Science ®Google Scholar
• Sargen MR, Cahoon EK, Lynch CF, et al. Sebaceous carcinoma incidence and survival among solid organ transplant recipients in the United States, 1987–2017. JAMA Dermatol. 2020;156(12):1307–1314. doi:10.1001/jamadermatol.2020.3111
   PubMed Web of Science ®Google Scholar
• Bhat M, Mara K, Dierkhising R, et al. Immunosuppression, race, and donor-related risk factors affect de novo cancer incidence across solid organ transplant recipients. Mayo Clin Proc. 2018;93(9):1236–1246. doi:10.1016/j.mayocp.2018.04.025
   PubMed Web of Science ®Google Scholar
• Wang R, Wang SP, Sun D, et al. Age and gender disparity of living donor renal transplantation. Int J Transplant Blood Hemopurification. 2018;16(4):23–26. doi:10.3760/cma.j.issn.1673-4238.2018.04.007
   Google Scholar
• Steinberg WM. Acute drug and toxin induced pancreatitis. Hosp Pract. 1985;20(5):95–102. doi:10.1080/21548331.1985.11703057
   Web of Science ®Google Scholar
• Elmore MF, Rogge JD. Tetracycline-induced pancreatitis. Gastroenterology. 1981;81(6):1134–1136. doi:10.1016/S0016-5085(81)80024-8
   PubMed Web of Science ®Google Scholar
• Rodvold KA, Gotfried MH, Cwik M, et al. Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose. J Antimicrob Chemother. 2006;58(6):1221–1229. doi:10.1093/jac/dkl403
   PubMed Web of Science ®Google Scholar